Using a robust genome-wide DNA methylation profiling approach, we show no consistent large-effect DNA methylation differences for CD4+ T cells, CD8+ T cells or WB in a homogenous collection of MS patients and controls. The gene discussed is CD8A; the disease is myeloid sarcoma.